Millennium Management’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-60,319
Closed -$1.05M 4177
2024
Q1
$1.05M Buy
+60,319
New +$1.05M ﹤0.01% 2931
2023
Q2
Sell
-18,154
Closed -$56K 4419
2023
Q1
$56K Sell
18,154
-7,849
-30% -$24.2K ﹤0.01% 4187
2022
Q4
$103K Sell
26,003
-93,293
-78% -$370K ﹤0.01% 4296
2022
Q3
$451K Buy
119,296
+74,318
+165% +$281K ﹤0.01% 3916
2022
Q2
$600K Sell
44,978
-40,062
-47% -$534K ﹤0.01% 3764
2022
Q1
$421K Sell
85,040
-36,192
-30% -$179K ﹤0.01% 4186
2021
Q4
$831K Buy
121,232
+31,735
+35% +$218K ﹤0.01% 3625
2021
Q3
$2.76M Sell
89,497
-15,536
-15% -$479K ﹤0.01% 2746
2021
Q2
$3.41M Buy
105,033
+33,130
+46% +$1.08M ﹤0.01% 2576
2021
Q1
$2.72M Sell
71,903
-19,288
-21% -$729K ﹤0.01% 2591
2020
Q4
$4.32M Sell
91,191
-35,467
-28% -$1.68M ﹤0.01% 2006
2020
Q3
$4.09K Sell
126,658
-25,787
-17% -$832 0.01% 1568
2020
Q2
$6.71M Buy
152,445
+6,067
+4% +$267K 0.01% 1199
2020
Q1
$4.8M Buy
146,378
+50,729
+53% +$1.66M 0.01% 1085
2019
Q4
$4.89M Buy
95,649
+1,870
+2% +$95.5K 0.01% 1580
2019
Q3
$3.45M Buy
93,779
+17,871
+24% +$658K 0.01% 1696
2019
Q2
$4.2M Buy
75,908
+529
+0.7% +$29.2K 0.01% 1607
2019
Q1
$4.59M Buy
75,379
+36,334
+93% +$2.21M 0.01% 1555
2018
Q4
$2.31M Sell
39,045
-7,333
-16% -$434K ﹤0.01% 1873
2018
Q3
$3.75M Buy
46,378
+17,858
+63% +$1.44M ﹤0.01% 1768
2018
Q2
$2.5M Buy
28,520
+20,147
+241% +$1.76M ﹤0.01% 1996
2018
Q1
$1.62M Buy
+8,373
New +$1.62M ﹤0.01% 2256
2017
Q1
Sell
-145
Closed -$11K 3357
2016
Q4
$11K Buy
+145
New +$11K ﹤0.01% 3069
2015
Q1
Sell
-25
Closed -$52K 3168
2014
Q4
$52K Buy
25
+3
+14% +$6.24K ﹤0.01% 3163
2014
Q3
$44K Sell
22
-66
-75% -$132K ﹤0.01% 2837
2014
Q2
$311K Buy
88
+59
+203% +$209K ﹤0.01% 2380
2014
Q1
$110K Sell
29
-268
-90% -$1.02M ﹤0.01% 2520
2013
Q4
$970K Sell
297
-297
-50% -$970K ﹤0.01% 1857
2013
Q3
$2.48M Buy
594
+167
+39% +$698K 0.01% 1239
2013
Q2
$1.44M Buy
+427
New +$1.44M ﹤0.01% 1451